2023 data FDA MAUDE openFDA FDA Class III

Multi-Analyte Test System With Algorithmic Analysis For Detection Of Prostate Cancer

Adverse-event figures are drawn from the U.S. Food & Drug Administration (FDA) MAUDE database, refreshed March 2026, see our methodology.

OpenFDA device adverse-event casebook.

FDA MAUDE casebook

openFDA event book Multi-Analyte Test System With Algorithmic… LIGHT-BOOK · MAUDE

#992 of 1000 · 371 reports · 2023–2023

  • BOOK 371 reports
  • RANK #992 of 1000
  • DEATH 0 death-typed
  • INJ 0 injury-typed
  • MALF 371 malfunction
  • SPAN 2023–2023
  • PEAK 2023: 371
  • PHOTO Antigens

Nearest event-volume peer: Antigens, All Groups, Streptococcus Spp. (1 report gap)

Multi-Analyte Test System With Algorithmic Analysis For Detection Of Prostate Cancer sits #992 of 1000 among tracked device types with 371 MAUDE reports spanning 2023–2023. Rank counts report volume, not confirmed device fault. Event_type Death / Injury / Malfunction are one code per report — not the same population as patient-outcome rows ( methodology). Read with this device → · Similar-volume device →

Malfunction reports run above the device-type norm

Multi-Analyte Test System With Algorithmic… carries 100.0% MALFUNCTION-coded reports, 35.2pp above the 1,000-device-type mean, the widest gap of its three event codes. Codes are report labels, not adjudicated causation.

  • DEATH 0.0% corpus 1.5% · below corpus mean (-1.5 pp)
  • INJ 0.0% corpus 30.3% · below corpus mean (-30.3 pp)
  • MALF 100.0% corpus 64.8% · above corpus mean (+35.2 pp)

Lead product-problem code Application Program Version or Upgrade Problem is 100% of coded problems · Top event location is 100% of location-tagged rows .

Multi-Analyte Test System With Algorithmic… in the event-volume neighbourhood

FDA MAUDE report totals among this device type and nearest nationwide peers

reports

What this shows Multi-Analyte Test System With Algorithmic Analysis For Detection Of Prostate Cancer carries 371 MAUDE reports, ranked #992 of 1000.

Source FDA MAUDE via openFDA, aggregated by PlainHospital As of August 2026

Event Types

Malfunction 371 (100.0%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

Other 371 (100.0%)

Top Product Problems

Application Program Version or Upgrade Problem 371

Yearly Trend

23
2023: 371

Related Entities for Multi-Analyte Test System With Algorithmic Analysis For Detection Of Prostate Cancer

Event Locations

371 (100.0%)

Nationwide devices with a comparable report-volume footprint

Multi-Analyte Test System With Algorithmic… carries zero death-typed MAUDE reports, so the peer set below compares report volume only; both axes are floored at ≥100 reports so the neighborhood stays in the advertised mass.

Similar report volume

Nearest other device types by FDA MAUDE report count (371 here).

Similar death-typed counts

Nearest other device types by death-typed report count (0 here), distinct from the volume row.

Disclaimer: MAUDE figures for Multi-Analyte Test System With Algorithmic… are informational only and are not clinical advice. Report codes do not prove device causation. Consult a qualified clinician before acting on this data.

Every figure on PlainHospital is rendered directly from federal source data, no number is typed in by an editor. Event-type mix on this page is computed from FDA MAUDE codes for Multi-Analyte Test System With Algorithmic…; corpus means use device types with ≥100 reports. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.